Loading...
NIR responsive tumor vaccine in situ for photothermal ablation and chemotherapy to trigger robust antitumor immune responses
BACKGROUND: Therapeutic tumor vaccine (TTV) that induces tumor-specific immunity has enormous potentials in tumor treatment, but high heterogeneity and poor immunogenicity of tumor seriously impair its clinical efficacy. Herein, a novel NIR responsive tumor vaccine in situ (HA-PDA@IQ/DOX HG) was pre...
Saved in:
| Published in: | J Nanobiotechnology |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8130144/ https://ncbi.nlm.nih.gov/pubmed/34001148 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12951-021-00880-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|